Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

CUSIP: 03836J201

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
9,144,889
Total 13F shares
1,815,508
Share change
-33,675
Total reported value
$3,072,270
Price per share
$1.69
Number of holders
23
Value change
-$77,601
Number of buys
7
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 03836J201?
CUSIP 03836J201 identifies APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q2 2025

As of 30 Jun 2025, Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,815,508 shares. The largest 10 holders included AIGH Capital Management LLC, Sio Capital Management, LLC, SPHERA FUNDS MANAGEMENT LTD., Nantahala Capital Management, LLC, VANGUARD GROUP INC, DAFNA Capital Management LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, LANDSCAPE CAPITAL MANAGEMENT, L.L.C., and LPL Financial LLC. This page lists 23 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.